Back to BYSIView Full LandscapeView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
14 competitors in Non-Small Cell Lung Cancer
REGNLibtayo
Phase 3MRKArm A: Pemetrexed Cisplatin
Phase 2SNYoxaliplatine / gemcitabine / Vinorelbine
Phase 2RHHBYerlotinib HCl
Phase 2BNTXBNT327
Phase 2Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Docetaxel + Plinabulin (DP)Phase 3
Non-Small Cell Lung Cancer
PlinabulinPhase 3
Chemotherapy-induced Neutropenia
PegfilgrastimPhase 3
Chemotherapy-induced Neutropenia
Nitric OxidePhase 3
Bronchiolitis
Docetaxel, doxorubicin, and cyclophosphamide (TAC)Phase 2
Chemotherapy-induced Neutropenia
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
